greeksoup/ stock research

Medpace Holdings (MEDP) Q3 FY2026 earnings: revenue $716 million, up 8.5% on the year

Medpace Holdings, Inc. (MEDP) announced its results for Q3 FY2026, the quarter ended 30 September 2026, on 21 October 2026. Revenue was $716 million, up 8.5% on the same quarter a year earlier. Net income was $137 million, up 23.7% on the year, and diluted earnings per share $4.84. The figures are from the company's earnings press release; the 10-Q with the full statements is not filed yet, and this page fills in when it is.

Revenue$716 millionup 8.5%
Net income$137 millionup 23.7%
Diluted EPS$4.84$3.86 a year earlier
QuarterQ3 FY2026ended 30 September 2026

The quarter, against the one before and a year earlier

LineQ3 FY2026Q2 FY2026Q3 FY2025Change on the year
Revenue716707660+8.5%
Net income137121111+23.7%
Diluted EPS$4.84$4.25$3.86+25.4%
$ million except per share.
Read moreQ3 FY2026 is from the company's press release of 21 October 2026; the other columns are from its 10-Q and 10-K filings. A release figure is shown when the release's own figure for an earlier quarter matches the filed one, so the line and its units are read right.

Quarterly results, the last 20 quarters filed

Q3 FY2021Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue296309331351384394434461492498511528533537559603660708707707
SG&A28.027.729.433.235.433.438.039.441.442.544.141.549.245.457.946.748.144.947.948.1
Operating income53.754.964.260.277.876.486.278.484.987.3104105112125114126142153142147
Operating margin18%18%19%17%20%19%20%17%17%18%20%20%21%23%20%21%21%22%20%21%
Pre-tax income54.755.965.362.081.973.686.075.783.290.7113110119134118125143157148152
Tax rate11%11%6%20%19%7%15%19%15%14%9%20%19%13%3%28%22%14%16%20%
Net income48.650.061.349.466.068.772.961.170.578.310388.496.411711590.3111135124121
Net margin16%16%19%14%17%17%17%13%14%16%20%17%18%22%21%15%17%19%18%17%
Diluted EPS$1.29$1.32$1.69$1.46$2.05$2.12$2.27$1.93$2.22$2.46$3.20$2.75$3.01$3.67$3.67$3.10$3.86$4.67$4.28$4.25
Operating cash flow72.470.946.396.610813780.182.5114156153116149191126149246193152162
Capital expenditure6.69.19.311.27.29.29.58.48.710.05.512.910.57.610.06.110.74.56.823.9
Free cash flow65.761.837.085.410112770.674.1106146147104139183116142235188145138
Buybacks6.20.04263750.047.212023.90.00.00.00.00.01703725414.60.00.0295
Shares outstanding36m36m34m31m31m31m31m31m31m31m31m31m31m31m30m28m28m28m29m28m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Earnings press release for the quarter ended 30 September 2026, filed with the SEC on 21 October 2026 with a Form 8-K: the release.